New Information Revealed About The Link Between Neurodegenerative Diseases and Aging

According to a story from hms.harvard.edu, a recent study is revealing new information about the connection between aging and neurodegenerative disorders, such as Parkinson's disease, dementia, and amyotrophic lateral sclerosis.…

Continue Reading New Information Revealed About The Link Between Neurodegenerative Diseases and Aging
Two Studies Investigated the Long-Term Effects of Subthalamic Deep Brain Stimulation as a Treatment for Parkinson’s Disease
Skitterphoto / Pixabay

Two Studies Investigated the Long-Term Effects of Subthalamic Deep Brain Stimulation as a Treatment for Parkinson’s Disease

Two studies have looked into the long-term effects of subthalamic deep brain stimulation as a treatment for Parkinson’s disease. For more detailed information on this topic, you can find the…

Continue Reading Two Studies Investigated the Long-Term Effects of Subthalamic Deep Brain Stimulation as a Treatment for Parkinson’s Disease

It Looks Like Drug Developers Will Start Using 23andMe Data to Create New Therapies

According to a story from pcmag.com, the pharmaceutical company GlaxoSmithKline (GSK) has recently partnered with 23andMe as part of a four year long agreement that will grant the company exclusive…

Continue Reading It Looks Like Drug Developers Will Start Using 23andMe Data to Create New Therapies
ICYMI: Recruitment Has Begun For a Phase I Clinical Trial of A Drug Designed to Treat Parkinsonian Diseases
qimono / Pixabay

ICYMI: Recruitment Has Begun For a Phase I Clinical Trial of A Drug Designed to Treat Parkinsonian Diseases

Prana Biotechnology has announced that it has begun recruiting healthy volunteers for its Phase I clinical trial of the experimental drug PBT434. The drug is thought to affect processes linked…

Continue Reading ICYMI: Recruitment Has Begun For a Phase I Clinical Trial of A Drug Designed to Treat Parkinsonian Diseases
The First Patient Has Been Dosed in the Third Cohort of a Phase I Trial For a Potential Parkinson’s Disease Treatment
ColiN00B / Pixabay

The First Patient Has Been Dosed in the Third Cohort of a Phase I Trial For a Potential Parkinson’s Disease Treatment

The first patient has undergone stem cell transplant treatment in the third cohort of a Phase I clinical study of the experimental treatment ISC-hpNSC for Parkinson’s disease. The full article can…

Continue Reading The First Patient Has Been Dosed in the Third Cohort of a Phase I Trial For a Potential Parkinson’s Disease Treatment
Phase 1 Trial Set to Begin For Experimental Therapy For Multiple System Atrophy and Progressive Supranuclear Palsy
source: pixabay.com

Phase 1 Trial Set to Begin For Experimental Therapy For Multiple System Atrophy and Progressive Supranuclear Palsy

According to a story from businesswire.com, the company Prana Biotechnology Ltd recently announced that it is beginning the recruitment process for its Phase 1 clinical trial of its investigational product…

Continue Reading Phase 1 Trial Set to Begin For Experimental Therapy For Multiple System Atrophy and Progressive Supranuclear Palsy
Man is Scammed for Unsuccessful Stem Cell Transplant for Lung Disease
source: pixabay.com

Man is Scammed for Unsuccessful Stem Cell Transplant for Lung Disease

New research is showing that patients sometimes use crowdfund websites to pay for fake stem cell transplants and other dubious medical procedures, according to a story from medicalxpress.com. Crowdfunding websites…

Continue Reading Man is Scammed for Unsuccessful Stem Cell Transplant for Lung Disease
Anavex Plans to Trial its Treatment For Parkinson’s Disease Dementia, and Researchers are Hopeful that it Could Also Benefit Other Diseases
Source: Pixabay

Anavex Plans to Trial its Treatment For Parkinson’s Disease Dementia, and Researchers are Hopeful that it Could Also Benefit Other Diseases

A drug called Anavex 2-73 being developed to treat Parkinson’s disease dementia is planned to undergo testing in a Phase 2 clinical trial, reports Globe Newswire. Parkinson’s disease is a…

Continue Reading Anavex Plans to Trial its Treatment For Parkinson’s Disease Dementia, and Researchers are Hopeful that it Could Also Benefit Other Diseases
Recent Surveys Show What Patients Really Think About Their Standard of Care
Source: Pixabay

Recent Surveys Show What Patients Really Think About Their Standard of Care

An organisation called PatientsLikeMe that helps to represent patients to governments and pharmaceutical companies has published a press release about the results of two recent studies designed to define and…

Continue Reading Recent Surveys Show What Patients Really Think About Their Standard of Care
Simple Bedside Test May Help Doctors Diagnose Certain Degenerative Brain Diseases
Source: Pixabay

Simple Bedside Test May Help Doctors Diagnose Certain Degenerative Brain Diseases

Neurologists working at the NYU School of Medicine have developed a test that can identify some rare degenerative brain diseases, reports NYU Langone Health. Published in the Annals of Neurology…

Continue Reading Simple Bedside Test May Help Doctors Diagnose Certain Degenerative Brain Diseases
Parkinson’s Disease Advocates Will Converge in DC For The Parkinson’s Policy Forum
source: pixabay.com

Parkinson’s Disease Advocates Will Converge in DC For The Parkinson’s Policy Forum

According to a story from markets.financialcontent.com, approximately 300 Parkinson's disease advocates and disease experts are slated to meet in Washington, DC for the Parkinson's Policy Forum. This year, the event…

Continue Reading Parkinson’s Disease Advocates Will Converge in DC For The Parkinson’s Policy Forum